Anzeige
❌
Mehr »
Montag, 26.10.2026 - Börsentäglich über 12.000 News
8 Millionen CAD eingesammelt, 21,45% Antimon entdeckt: Kanadas Bald-Hill-Projekt startet in die nächste Phase
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
07:42RBC downgrades Equifax stock rating on mortgage weakness concerns
07:30SBFC Finance Q2 FY27 slides: 27% growth amid market caution
07:30Jupiter Hospital Q2FY27 slides: revenue rises, expansion weighs on profit
07:30Gerdes downgrades Range Resources stock rating to neutral on valuation
07:30Jefferies upgrades Orion stock on Nubeqa patent outlook
07:30JPMorgan initiates Accelevation stock with overweight rating
06:06Unicommerce Q2 FY27 slides: 15% growth amid strategic AI investments
02:06Ramelius Q1 FY27 slides: cash surges to A$768M as growth ramps
02:066K Additive Q3 2026 slides: record backlog drives expansion plans
02:06Greatland Q1 FY27 slides: production beats, Havieron underway
00:42Mach7 Q1 FY27 slides: cash flow positive, Flamingo launch ahead
00:42Stifel raises ORIC Pharmaceuticals price target to $18 on ESMO data
00:30Oppenheimer reiterates Amgen stock rating on cancer drug data
00:30Stifel raises Hinge Health stock price target on app growth rebound
00:30Nokia stock rating upgraded to Reduce by IndeRes on strong Q3 results
00:30IndeRes upgrades Nokia stock rating on strong Q3 results
00:30RBC reiterates Intel stock rating on AI demand, foundry progress
SoJefferies upgrades Dr. Reddy's stock rating on margin outlook
SoArriVent reports phase 1 data for cancer drug ARR-217
SoAmarin's icosapent ethyl shows survival benefit in cancer trial
SoNovaBridge reports phase 1b data for gastric cancer drug
SoGenmab reports phase 2 trial data for colorectal cancer drug
SoBrookfield to open Qatar office as it expands Middle East operations
SoXencor reports phase 1 data for cancer drug XmAb819
SoBioNTech, Bristol Myers report lung cancer trial data